BUPRENORPHINE AND NALOXONE
Generic: BUPRENORPHINE AND NALOXONE
Sun Pharmaceutical IndustriesManufacturer
SUBLINGUALRoute
BUPRENORPHINE HYDROCHLORIDEActive Substance
2016-08-05Original Approval
BUPRENORPHINE AND NALOXONE is FDA application ANDA201633, sponsored by SUN PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2021-02-26
Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: AlvoSubpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Class II2022-10-18
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun PharmaceuticalPresence of Foreign Substance
Top Reported Reactions
1
DRUG DEPENDENCE
174 reports
2
NAUSEA
155 reports
3
DRUG WITHDRAWAL SYNDROME
117 reports
4
DRUG INEFFECTIVE
109 reports
5
VOMITING
94 reports
6
HEADACHE
92 reports
7
PAIN
92 reports
8
INJECTION SITE REACTION
91 reports
9
FOETAL EXPOSURE DURING PREGNANCY
85 reports
10
WITHDRAWAL SYNDROME
85 reports